Novel Autism Diagnostics Study 2016 Featuring Asuragen, Google Genomics, Illumina, and LabCorp

Dublin, Feb. 29, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/qk6p8t/novel_autism) has announced the addition of the "Novel Autism Diagnostics" report to their offering.

Autism spectrum disorder (ASD) includes many syndromes that can range in severity from the social awkwardness and narrow interests to severe communication and intellectual disabilities. There is a growing demand for cost efficient tests that can help physicians diagnose and monitor chronic diseases such autism. There is therefore a market opportunity for highly sensitive, specific and cost effective screening tests for early diagnosis. Novel Autism Diagnostics examines selected autism test innovations that have emerged.

Novel Autism Diagnostics outlines many of the current approaches to autism testing, including molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well.

The competitors discussed within the company profiles include Asuragen, Google Genomics, Illumina, and LabCorp.

The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.

Key Topics Covered:

ONE: EXECUTIVE SUMMARY
Overview of ASD
Leading Competitors
Methodology

TWO: NOVEL AUTISM DIAGNOSTICS
Overview of Autism
Screening and Diagnosis
Developmental Screening
Comprehensive Diagnostic Evaluation
Emerging Diagnostics
Potential Market
Research

THREE: COMPANY PROFILES
Ambry Genetics Corp.
ARUP Laboratories
Asuragen Inc.
Controls
Sample Collection
Sequencing
Athena Diagnostics, Inc. (A Quest Diagnostics Business)
Claritas Genomics, Inc.
CombiMatrix Corp.
Oncology
Courtagen Life Sciences, Inc.
Emory Genetics Laboratory
GenePeeks, Inc.
Genoma SA (a Subsidiary of the Esperite group)
Google Genomics
Greenwood Genetic Center
Illumina
Sequencing
Sequencing Kits
Sample Prep
IVD Business
Oncology
HLA Typing
IT
Forensics
CLIA Lab Service
Nanopore Sequencing
Sample to Insight
Making a Market
IP Situation
IntegraGen
LabCorp, Laboratory Corporation of America
Infectious Diseases
Prenatal
Sequencing
Oncology
BRCA Saga
Information Technology
Forensic
Collaborations
Life Technologies Corporation
Instrumentation and Applications
Liquid Biopsy
Sequencing
Life Technologies an IVD Company
Partnerships Worldwide
Life and Quidel Develop Diagnostics on the 7500 Fast Dx
Sepsis
HIV
Emerging Pathogens
Bacterial Typing
Personalized Medicine
Forensic
Lineagen, Inc.
MEDomics, LLC
Population Diagnostics
RainDance Technologies, Inc.
SynapDx Corporation
Transgenomic, Inc.

For more information visit http://www.researchandmarkets.com/research/qk6p8t/novel_autism

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Diagnostics